Tags

Type your tag names separated by a space and hit enter

Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.
Prog Cardiovasc Dis. 2020 May-Jun; 63(3):383-385.PC

Links

PMC Free PDF

Authors+Show Affiliations

McCarty MF
Catalytic Longevity Foundation, United States of America.
DiNicolantonio JJ
Mid America Heart Institute, St. Luke's Hospital, United States of America. Electronic address: jjdinicol@gmail.com.

MeSH

AnimalsAntioxidantsAntiviral AgentsBetacoronavirusCOVID-19Coronavirus InfectionsDietary SupplementsEnzyme InhibitorsHost Microbial InteractionsHumansHydrogen PeroxideImmunologic FactorsInfluenza, HumanInterferon Type INADPH Oxidase 2OrthomyxoviridaePandemicsPneumonia, ViralSARS-CoV-2Toll-Like Receptor 7VirulenceCOVID-19 Drug Treatment

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32061635

Citation

McCarty, Mark F., and James J. DiNicolantonio. "Nutraceuticals Have Potential for Boosting the Type 1 Interferon Response to RNA Viruses Including Influenza and Coronavirus." Progress in Cardiovascular Diseases, vol. 63, no. 3, 2020, pp. 383-385.
McCarty MF, DiNicolantonio JJ. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Prog Cardiovasc Dis. 2020;63(3):383-385.
McCarty, M. F., & DiNicolantonio, J. J. (2020). Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Progress in Cardiovascular Diseases, 63(3), 383-385. https://doi.org/10.1016/j.pcad.2020.02.007
McCarty MF, DiNicolantonio JJ. Nutraceuticals Have Potential for Boosting the Type 1 Interferon Response to RNA Viruses Including Influenza and Coronavirus. Prog Cardiovasc Dis. 2020;63(3):383-385. PubMed PMID: 32061635.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. AU - McCarty,Mark F, AU - DiNicolantonio,James J, Y1 - 2020/02/12/ PY - 2020/2/18/pubmed PY - 2020/8/18/medline PY - 2020/2/17/entrez SP - 383 EP - 385 JF - Progress in cardiovascular diseases JO - Prog Cardiovasc Dis VL - 63 IS - 3 SN - 1873-1740 UR - https://www.unboundmedicine.com/medline/citation/32061635/Nutraceuticals_have_potential_for_boosting_the_type_1_interferon_response_to_RNA_viruses_including_influenza_and_coronavirus_ DB - PRIME DP - Unbound Medicine ER -